Zydus Lifesciences
Indian multinational pharmaceutical company
Zydus Lifesciences ▸ Facts ▸ Comments ▸ News ▸ Videos
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacture of generic drugs. It ranked 100th in the Fortune India 500 list in 2020.
| 0 shares | ShareTweetSavePostSend |
You Might Like
Zydus 2-dose Covid-19 vaccine gets regulatory nodIndiaTimes - Published | |
DCGI grants approval to Corbevax for kids aged 5-12, Covaxin for 6-12 age groupThe Drug Controller General of India (DCGI) on Tuesday granted emergency use approval to Covid-19 vaccines, Covaxin and Corbevax, for children below 12. Bharat Biotech's Covaxin has got nod for use in..IndiaTimes - Published | |
2-shot Zydus vaccine may be rolled out soonSoon a two-shot Covid-19 vaccine of Zydus LifeSciences could be rolled out, instead of the three-shot regimen currently approved. The company has received approval from the Subject Expert Committee..IndiaTimes - Published | |
Covid-19: Two shot vaccine by Zydus gets SEC nodSoon a two-shot Covid-19 vaccine of Zydus Cadila could be rolled out, instead of the three-shot regimen currently approved. The company has received approval from the Subject Expert Committee (SEC)..IndiaTimes - Published | |
Zydus starts supply of its needle-free 3-dose vaccination to govtPharma major Zydus Cadila said on Wednesday it has started supplying its Covid-19 vaccine ZyCoV-D to the Centre, nearly six months after it had been authorised for emergency use in the 12 and above age..IndiaTimes - Published | |
Zydus starts delivery of needless Covid-19 vaccines to central governmentThe company is also planning to make the vaccine available in the private market.DNA - Published | |
Zydus Cadila's COVID-19 vaccine ZyCoV-D to be launched in THESE seven states initiallyZydus Cadila's COVID-19 vaccine ZyCoV-D will be introduced in seven Indian states in the first rollout, as per the health ministry.DNA - Published | |
Zydus Cadila gets USFDA nod to market generic cancer drug in USIndiaTimes - Published | |
Zydus Cadila's Covid vaccine to be administered only to adults as of now: SourcesZydus Cadila's COVID-19 vaccine ZyCov-D, which has been cleared by India's drug regulator for those aged 12 years and above, will only be administered to adults as of now under the government's..IndiaTimes - Published | |
Zydus Cadila to supply 1 crore doses of its 'needle-free' COVID-19 vaccine to govt at this priceThe ZyCoV-D vaccine will be given through a needle-free applicator instead of a syringe.DNA - Published | |
India to buy 10 million doses of Zydus Cadila's Covid-19 vaccine at about $4 eachIndiaTimes - Published | |
Zydus Cadila agrees to reduce its Covid vaccine price to Rs 265 a dose, final decision soon: SourcesIndiaTimes - Published | |
Procurement price of Zydus vax fixed, roll out soon: GovtIndiaTimes - Published | Kids’ vaccine ZyCoV-D to be given to private hospitals tooThe needle-free ZyCoV-D vaccine, manufactured by Zydus Cadila, has received emergency use authorisation for being administered to children between 12 and 17 years of age in India. The three-dose..IndiaTimes - Published |
Zydus Cadila proposes Rs 1900 for three-dose Covid vaccine; government negotiating to bring it downIndiaTimes - Published | 'Centre hopeful of positive outcome from final talks with Zydus Cadila for Covid vaccine for kids'The Centre is hopeful of a positive outcome from the final round of discussions currently underway with Zydus Cadila for its Covid-19 vaccine for children, Karnataka Health Minister K Sudhakar said on..IndiaTimes - Published |
Covid: Zydus vaccine to be introduced in inoculation drive soonIndiaTimes - Published | Centre likely to roll out 1 crore doses of Zydus Cadila's COVID-19 vaccine ZyCoVD by October - All you need to knowOn PM Narendra Modi's 71st birthday, India set a new record for single-day vaccinations and administered over 2 crore COVID-19 vaccine doses.DNA - Published |
Zydus Cadila to seek approval for two-dose regimen of its approved three-dose Covid-19 vaccine in IndiaIndiaTimes - Published | Zydus Cadila's Covid-19 vaccine can be available from first week of OctoberThe Union government is expecting Zydus Cadila's needle-free Covid-19 vaccine ZyCoV-D to be available from the first week of October. Further, a decision on whether all children or only those with..IndiaTimes - Published |
ZyCoV-D COVID vaccine likely to be available in market by mid to end September: MD Sharvil PatelThe ZyCoV-D COVID-19 vaccine, which received emergency use authorisation from India's drug regulator on Friday, will be available in the market by mid to end September, Zydus Group Managing Director..DNA - Published | A momentous feat: PM Narendra Modi after Zydus Cadila's Covid vaccine gets emergency use authorisationThe department of biotechnology on Friday said indigenously developed Zydus Cadila Covid-19 vaccine ZyCoV-D has received approval for emergency use authorisation from the Drug Controller General of..IndiaTimes - Published |
Government approves first Covid-19 vaccine for children above 12 yearsThe company has indicated an initial visibility of supplying around 5 crore doses by December, a senior official said. While the government is yet to sign a final agreement with Cadila, supplies to the..IndiaTimes - Published | Government panel recommends emergency use authorisation to Zydus Cadila's 3-dose Covid vaccineThe subject expert committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) deliberated on the application given by Zydus Cadila on Thursday and recommended granting..IndiaTimes - Published |
Covid vaccination for kids may start only by March ’22Zydus Cadila's Covid-19 vaccine, ZyCoV-D, is expected to get an emergency use authorisation for the 12-18 cohort by end of August, whereas Bharat Biotech’s Covaxin – the world’s only vaccine..IndiaTimes - Published | AIIMS to begin second dose trial of Bharat Biotech's Covaxin on children between 2-6 yearsNot just Bharat Biotech's Covaxin but Zydus Cadila's vaccine for children is also currently under trial in IndiaDNA - Published |
DCGI likely to approve Zydus Cadila's vaccine for children above 12 yearsZydus Cadila's COVID-19 vaccine, ZyCov-D, is a three-dose, intradermal vaccine which is applied using the PharmaJet needle-free systemDNA - Published | Zydus’ vaccine for kids above 12 to come up for approval this weekThe vaccine has been tested on adults as well as children above 12 and if the regulatory committee is satisfied with the submitted data and documents, the vaccine will be approved for emergency use..IndiaTimes - Published |
Vaccination of children with Zydus vaccine will begin by September: Expert Panel ChiefVaccination of children with Zydus vaccine will begin by September. Focus on vaccinating children is due to threat perception for them in third wave.DNA - Published | Zydus seeks nod for world’s first plasmid DNA Covid vaxHomegrown healthcare and pharmaceutical major Zydus Cadila has applied for emergency use authorisation (EUA) to the office of the Drug Controller General of India for ZyCoV-D, its plasmid DNA vaccine..IndiaTimes - Published |
Zydus Cadila seeks approval for its 3-dose Covid vaccineIndian drugmaker Zydus Cadila said on Thursday it has applied for emergency use approval of its three-dose Covid-19 vaccine that showed efficacy of 66.6% in an interim study and could become the second..IndiaTimes - Published | Vaccination for Children: Zydus Cadila vaccine for 12-18 age group to be available soon, Centre informs Supreme CourtCentre tells SC that pharmaceutical company Zydus Cadila has concluded the clinical trials of its vaccine for the age group of 12 to 18.DNA - Published |
Zydus Cadila likely to seek emergency authorisation for ZyCoV-D Covid-19 vaccine in 7-8 daysPharmaceutical major Zydus Cadila has told the Centre that it could apply for emergency use authorisation (EUA) for ZyCoV-D vaccine in the next seven-eight days.IndiaTimes - Published | Vaccine for 12+: Zydus may seek licence in 2 weeksIndiaTimes - Published |
Zydus: 80% of enrolment over for vaccine trial in 12-18 age groupIndiaTimes - Published | Zydus Cadila seeks human trial approval for Covid-19 antibody cocktailIndia's Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild Covid-19. The treatment candidate, ZRC-3308, was earlier shown to reduce lung damage..IndiaTimes - Published |
